Membranous nephropathy: an overview.
Membranous nephropathy (MN) accounts for about 20 percent of cases of the nephrotic syndrome. The importance of renal biopsy in establishing the diagnosis is emphasized. In the great majority of MN patients, no etiologic factor can be discerned. In a significant minority, MN appears to be a manifestation of sarcoidosis, diabetes, lupus, syphilis, malaria, or toxicity from heavy metals or drugs. In some cases the "cause" is neoplasia (including lymphoma) or a viral infection. Massive proteinuria, hypoproteinemia and edema are the principal manifestations of MN, finally resulting in renal failure. Treatment consists chiefly of diet and diuretic drugs. In the more pronounced cases, corticosteroids may have a favorable effect and in very resistant cases, cyclophosphamide is indicated. Judicious use of these modalities if often associated with the diminution or disappearance of the clinical signs of MN.
D000328:Adult; D000368:Aged; D001485:Basement Membrane / Q000473:pathology*; D002196:Capillaries / Q000473:pathology; D002648:Child; D003176:Complement C3 / Q000302:isolation & purification; D004039:Diet, Sodium-Restricted; D004232:Diuretics / Q000627:therapeutic use; D004848:Epithelium / Q000473:pathology; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000302:isolation & purification; D007678:Kidney Glomerulus / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009401:Nephrosis / Q000150:complications* / Q000276:immunology; D009404:Nephrotic Syndrome / Q000209:etiology* / Q000473:pathology
D003176:Complement C3; D004232:Diuretics; D007074:Immunoglobulin G